Aurobindo Pharma surges on getting USFDA’s nod for Esmolol Hydrochloride Injection

27 Jul 2015 Evaluate

Aurobindo Pharma is currently trading at Rs. 748.80, up by 13.85 points or 1.88% from its previous closing of Rs. 734.95 on the BSE.

The scrip opened at Rs. 735.00 and has touched a high and low of Rs. 751.75 and Rs. 722.70 respectively. So far 125065 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 776.75 on 20-Jul-2015 and a 52 week low of Rs. 329.40 on 30-Jul-2014.

Last one week high and low of the scrip stood at Rs. 776.75 and Rs. 718.00 respectively. The current market cap of the company is Rs. 42991.47 crore.

The promoters holding in the company stood at 53.92% while Institutions and Non-Institutions held 35.75% and 10.33% respectively.

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Esmolol Hydrochloride Injection, 100mg/10mL (10mg/mL), (ANDA 205520).

Esmolol Hydrochloride Injection, 100mg/10mL (10mg/mL) is bioequivalent and therapeutically equivalent to the reference listed drug product (RLD) Brevibloc Injection, 10mg/mL of Baxter Healthcare Corporation. Esmolol Hydrochloride Injection is indicated for the short-term treatment of tachycardia and hypertension that occur during induction and tracheal intubation, during surgery, on emergence from anesthesia and in the postoperative period.

Aurobindo now has 13 ANDAs (represented by 10 product classes) approved out of Unit IV formulation facility in Hyderabad, India for manufacturing general injectable products and will be marketed and sold by Aurobindo's wholly owned subsidiary AuroMedics Pharma LLC.

Aurobindo is a 'Vertically Integrated' pharmaceutical companies in India, It has robust product portfolio spread over major product areas encompassing CVS, CNS, Anti-Retroviral, Antibiotics, Gastroenterologicals, Anti-Diabetics and Anti-Allergic with approved manufacturing facilities by USFDA, UKMHRA, WHO, MCC-SA, ANVISA-Brazil for both APIs & Formulations.

 

Aurobindo Pharma Share Price

1291.40 43.45 (3.48%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×